<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02323698</url>
  </required_header>
  <id_info>
    <org_study_id>2017P001940b</org_study_id>
    <secondary_id>5R01HD081274</secondary_id>
    <nct_id>NCT02323698</nct_id>
  </id_info>
  <brief_title>Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury</brief_title>
  <official_title>The Effects of Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury (Caffeine Substudy)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Spaulding Rehabilitation Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accumulating evidence suggests that repeatedly breathing low oxygen levels for brief periods
      (termed intermittent hypoxia) is a safe and effective treatment strategy to promote
      meaningful functional recovery in persons with chronic spinal cord injury (SCI). The goal of
      the study is to understand how caffeine may augment the effects of intermittent hypoxia on
      motor function and spinal plasticity (ability of the nervous system to strengthen neural
      pathways based on new experiences) following SCI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will examine the effects of acute intermittent hypoxia (AIH) as a possible
      therapeutic intervention to promote functionally useful motor recovery. In this sub-study,
      the investigators will assess changes in leg motor function in response to repetitive AIH
      with and without caffeine.

      Participants will receive caffeine+AIH, placebo+AIH, caffine+SHAM in a randomized order.
      Before each intervention round, subjects will be asked to avoid caffeine-containing
      substances for 48 hrs (&gt; 5* half-life of ~7 hrs) prior to arrival to control for baseline
      plasma levels of caffeine. Subjects will then ingest capsules containing either placebo
      (dextrose) or caffeine (up to 6mg/kg). Capsules will be prepared by Johnson Compounding &amp;
      Wellness. Blood samples will be collected before and after the breathing intervention to
      assess caffeine concentrations within the body.

      During and after each intervention, both the rate and extent of magnitude changes in
      voluntary and involuntary muscle response behaviors important for walking will be compared
      between interventions within participants. Repeated measurements will be collected on all
      subjects that participate in the multiple interventions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Balanced design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in overground walking speed</measure>
    <time_frame>Baseline after intervention (day 5), and at follow-ups (one week and two weeks)</time_frame>
    <description>Speed will be assessed by the time required to walk 10 meters (10MWT).</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <arm_group>
    <arm_group_label>Caffeine/AIH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with chronic, motor-incomplete SCI receive Caffeine then AIH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo/AIH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with chronic, motor-incomplete SCI receive Placebo then AIH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caffeine/SHAM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with chronic, motor-incomplete SCI receive Caffeine then SHAM</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>Subjects will ingest capsules containing caffeine (up to 6mg/kg). Experiments will begin 30min after consumption to approximately coincide with peak plasma concentrations.Throughout the 30min wait time and experimentation, blood pressure and heart rate will be monitored.</description>
    <arm_group_label>Caffeine/AIH</arm_group_label>
    <arm_group_label>Caffeine/SHAM</arm_group_label>
    <other_name>caffeine anhydrous</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>AIH</intervention_name>
    <description>Participants will breathe intermittent low oxygen via air generators. The generators will fill reservoir bags attached to a non-rebreathing face mask. Oxygen concentration will be continuously monitored to ensure delivery of FIO2 (fraction of inspired oxygen) = 0.10±0.02 (hypoxia). Throughout experimentation, blood pressure and heart rate will be monitored.</description>
    <arm_group_label>Caffeine/AIH</arm_group_label>
    <arm_group_label>Placebo/AIH</arm_group_label>
    <other_name>Acute intermittent hypoxia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>This is a placebo counterpart to the caffeine drug. Subjects will ingest capsules containing dextrose. Experiments will begin 30min after consumption to mimic the caffeine drug protocol. Throughout experimentation, blood oxygenation, blood pressure and heart rate will be monitored.</description>
    <arm_group_label>Placebo/AIH</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SHAM</intervention_name>
    <description>This is a placebo counterpart to breathing intermittent low oxygen. Participants will breathe intermittent room air via air generators. The generators will fill reservoir bags attached to a non-rebreathing face mask. Oxygen concentration will be continuously monitored to ensure delivery of FIO2 (fraction of inspired oxygen) = 0.21±0.02 (normoxia). Throughout experimentation, blood pressure and heart rate will be monitored.</description>
    <arm_group_label>Caffeine/SHAM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 and 75 years (the latter to reduce likelihood of heart disease)

          -  medical clearance to participate

          -  lesion at or below C2 and above L5 with non-progressive etiology

          -  classified as motor-incomplete with visible volitional leg movement

          -  injury greater than 6 months

          -  ability to advance one step overground without human assistance

        Exclusion Criteria:

          -  Concurrent severe medical illness (i.e., infection, cardiovascular disease,
             ossification, recurrent autonomic dysreflexia, unhealed decubiti, and history of
             pulmonary complications)

          -  Pregnant women because of the unknown affects of AIH on pregnant women and fetus

          -  History of seizures, brain injury, and/or epilepsy

          -  Undergoing concurrent physical therapy

          -  Diabetes

          -  Cirrhosis

          -  Caffeine and/or NSAID allergies or intolerances
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randy D Trumbower, PT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Randy D Trumbower, PT, PhD</last_name>
    <phone>(617) 952-6951</phone>
    <email>randy.trumbower@mgh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stella Barth, BA</last_name>
    <phone>(617) 952-6822</phone>
    <email>SBARTH@PARTNERS.ORG</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Spaulding Rehabilitation Hospital</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randy D Trumbower, PT, PhD</last_name>
      <phone>617-952-6951</phone>
      <email>randy.trumbower@mgh.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stella Barth, BA</last_name>
      <phone>(617) 952-6822</phone>
      <email>SBARTH@PARTNERS.ORG</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://inspire-lab.org</url>
    <description>INSPIRE Lab Website</description>
  </link>
  <reference>
    <citation>Trumbower RD. Stimulating the Injured Spinal Cord: Plenty to Grasp. J Neurotrauma. 2018 Sep 15;35(18):2143-2144. doi: 10.1089/neu.2018.5993.</citation>
    <PMID>30009669</PMID>
  </reference>
  <reference>
    <citation>Sohn WJ, Tan AQ, Hayes HB, Pochiraju S, Deffeyes J, Trumbower RD. Variability of Leg Kinematics during Overground Walking in Persons with Chronic Incomplete Spinal Cord Injury. J Neurotrauma. 2018 Nov 1;35(21):2519-2529. doi: 10.1089/neu.2017.5538. Epub 2018 Jun 5.</citation>
    <PMID>29648987</PMID>
  </reference>
  <reference>
    <citation>Trumbower RD, Hayes HB, Mitchell GS, Wolf SL, Stahl VA. Effects of acute intermittent hypoxia on hand use after spinal cord trauma: A preliminary study. Neurology. 2017 Oct 31;89(18):1904-1907. doi: 10.1212/WNL.0000000000004596. Epub 2017 Sep 29.</citation>
    <PMID>28972191</PMID>
  </reference>
  <reference>
    <citation>Peters DM, Thibaudier Y, Deffeyes JE, Baer GT, Hayes HB, Trumbower RD. Constraints on Stance-Phase Force Production during Overground Walking in Persons with Chronic Incomplete Spinal Cord Injury. J Neurotrauma. 2018 Feb 1;35(3):467-477. doi: 10.1089/neu.2017.5146. Epub 2017 Oct 27.</citation>
    <PMID>28762876</PMID>
  </reference>
  <reference>
    <citation>Hayes HB, Chvatal SA, French MA, Ting LH, Trumbower RD. Neuromuscular constraints on muscle coordination during overground walking in persons with chronic incomplete spinal cord injury. Clin Neurophysiol. 2014 Oct;125(10):2024-35. doi: 10.1016/j.clinph.2014.02.001. Epub 2014 Feb 14.</citation>
    <PMID>24618214</PMID>
  </reference>
  <reference>
    <citation>Hayes HB, Jayaraman A, Herrmann M, Mitchell GS, Rymer WZ, Trumbower RD. Daily intermittent hypoxia enhances walking after chronic spinal cord injury: a randomized trial. Neurology. 2014 Jan 14;82(2):104-13. doi: 10.1212/01.WNL.0000437416.34298.43. Epub 2013 Nov 27.</citation>
    <PMID>24285617</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 18, 2014</study_first_submitted>
  <study_first_submitted_qc>December 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spaulding Rehabilitation Hospital</investigator_affiliation>
    <investigator_full_name>Randy Trumbower, PT, PhD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>hypoxia</keyword>
  <keyword>spinal cord injury</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>strength</keyword>
  <keyword>walk</keyword>
  <keyword>function</keyword>
  <keyword>low oxygen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

